EsoCap is proud to congratulate Professor Werner Weitschies of the Institute of Pharmacy, Center of Drug Absorption and Transport – Biopharmaceutics and Pharmaceutical Technology at the University of Greifswald, on receiving the prestigious 2026 Pearls of Bioequivalence and Biopharmaceutics Award.
The award is jointly presented by the Frankfurt Foundation Quality of Medicines (FFQM) and the European Federation for Pharmaceutical Sciences (EUFEPS) and recognizes outstanding achievements that advance pharmaceutical science and patient care.
Professor Weitschies was honored for his project, “From Innovation to Impact: The First Drug Delivery System for Local Treatment of the Esophagus.” The project represents a pioneering advancement in targeted esophageal therapy and has significantly contributed to improving treatment options for patients with esophageal diseases.
The award ceremony took place on 29 May 2026 during the JOINT EUFEPS–SITELF Meeting, Naples 2026: “Advances in Pharmaceutical Sciences.” The award was presented by Professor Henning Blume, Chairman of the Frankfurt Foundation Quality of Medicines, together with Professor Giuseppe De Rosa, President of EUFEPS.
“We are delighted to see Professor Weitschies and his innovative work receive this distinguished international recognition,” said Isabelle Racamier, CEO of EsoCap AG. “His scientific leadership and dedication have been instrumental in translating innovative concepts into meaningful therapeutic solutions for patients suffering from esophageal disorders.”
